Ligand validation:6ZAW

EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZAW_EPE_A_408	76%	17%	0.126	0.962	1.58	2.05	3	3	0	0	100%	0.25
6ZAT_EPE_A_520	96%	13%	0.084	0.992	1.28	2.65	3	5	1	0	100%	0.33
6ZAV_EPE_A_509	91%	29%	0.099	0.987	1.05	1.76	-	4	0	0	100%	0.3
6ZAR_EPE_A_414	89%	24%	0.087	0.966	1.39	1.72	2	3	0	0	100%	0.6
4WX4_EPE_A_302	99%	53%	0.064	0.994	0.99	0.82	1	-	0	0	100%	1
2F9R_EPE_B_701	99%	44%	0.061	0.989	0.62	1.54	-	2	0	0	100%	1
1VSI_EPE_A_261	98%	15%	0.058	0.984	1.64	2.09	1	6	1	0	100%	1
1XX1_EPE_D_2004	98%	26%	0.063	0.987	0.79	2.15	1	6	1	0	100%	1
4WYD_EPE_B_503	98%	44%	0.065	0.989	0.93	1.23	1	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.